Publication: 3851

Publication: 3851

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood Adv vol 8 (12) 3189-3199

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 13

Parents:: 3257 3549 3711
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233339; U10CA180820, UG1CA233196 (ECOG-ACRIN); U10CA180888, UG1CA233230 (SWOG); R01CA139-83-01A1

Corr. Author:
Authors:: Tracy T. Batchelor Sharmila Giri Amy S. Ruppert Susan M. Geyer Scott E. Smith Nimish Mohile Lode J. Swinnen Jonathan W. Friedberg Brad S. Kahl Nancy L. Bartlett Eric D. Hsi Bruce D. Cheson Nina Wagner-Johnston Lakshmi Nayak John P. Leonard James L. Rubenstein

Networks:: CA824, CAPITAL, IL017, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, NY018, PA121

Study: CALGB-51101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: Clinical Trials and Observations